SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-080545
Filing Date
2020-07-02
Accepted
2020-07-02 16:10:13
Documents
2
Period of Report
2020-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023724d2_8k.htm 8-K 34412
2 EXHIBIT 10.25 tm2023724d2_ex10-25.htm EX-10.25 130316
  Complete submission text file 0001104659-20-080545.txt   166027
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 201009380
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences